Skip to Main Content

Paper Details

Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.
Expert Rev Vaccines
2
2020
Author NameAffiliation
James LogueNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Ian CrozierClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute
Jens H KuhnNational Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 3

Datasets